How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances.
Br J Clin Pharmacol January 14, 2020 DOI: 10.1111/bcp.14183 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Key points | The abstract proposes that deaths can aid clinicians and policy-makers in comprehending the risks associated with novel psychoactive substances. |
Abstract
How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances.